145 related articles for article (PubMed ID: 9756160)
1. Complex movement disorder associated with fluvoxamine.
Bronner IM; Vanneste JA
Mov Disord; 1998 Sep; 13(5):848-50. PubMed ID: 9756160
[No Abstract] [Full Text] [Related]
2. Fluvoxamine and mandibular dystonia.
Chong SA
Can J Psychiatry; 1995 Sep; 40(7):430-1. PubMed ID: 8548729
[No Abstract] [Full Text] [Related]
3. Citalopram and fluvoxamine in Tourette's disorder.
Bajo S; Battaglia M; Pegna C; Bellodi L
J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):230-1. PubMed ID: 10087681
[No Abstract] [Full Text] [Related]
4. Restlessness related to SSRI withdrawal.
Hirose S
Psychiatry Clin Neurosci; 2001 Feb; 55(1):79-80. PubMed ID: 11235863
[TBL] [Abstract][Full Text] [Related]
5. Dyskinesia associated with fluvoxamine.
Arya DK; Szabadi E
J Clin Psychopharmacol; 1993 Oct; 13(5):365-6. PubMed ID: 8227498
[No Abstract] [Full Text] [Related]
6. Extrapyramidal symptoms in a patient treated with fluvoxamine.
Wils V
J Neurol Neurosurg Psychiatry; 1992 Apr; 55(4):330-1. PubMed ID: 1583525
[No Abstract] [Full Text] [Related]
7. Fluvoxamine for symptomatic outpatients with COVID-19.
Wu PE; Austin E; Leong D
CMAJ; 2022 Feb; 194(7):E258. PubMed ID: 35045990
[No Abstract] [Full Text] [Related]
8. Violent acts associated with fluvoxamine treatment.
Okada F; Okajima K
J Psychiatry Neurosci; 2001 Sep; 26(4):339-40. PubMed ID: 11590975
[No Abstract] [Full Text] [Related]
9. Manic-switch induced by fluvoxamine in abstinent pure methamphetamine abusers.
Won M; Minabe Y; Sekine Y; Takei N; Kondo N; Mori N
J Psychiatry Neurosci; 2003 Mar; 28(2):134-5. PubMed ID: 12670131
[No Abstract] [Full Text] [Related]
10. Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: a case report.
Albayrak Y; Ekinci O
J Clin Psychopharmacol; 2012 Oct; 32(5):723-4. PubMed ID: 22926615
[No Abstract] [Full Text] [Related]
11. Toxicity with selective serotonin reuptake inhibitors.
Solomons K; Gooch S; Wong A
Am J Psychiatry; 2005 Jun; 162(6):1225. PubMed ID: 15930079
[No Abstract] [Full Text] [Related]
12. Increased libido in a woman treated with fluvoxamine: a case report.
Hori H; Yoshimura R; Nakamura J
Acta Psychiatr Scand; 2001 Apr; 103(4):312-4. PubMed ID: 11328247
[TBL] [Abstract][Full Text] [Related]
13. A display of hypomania in a depressed male in response to fluvoxamine.
Horiguchi T; Sai S
World J Biol Psychiatry; 2001 Oct; 2(4):201-4. PubMed ID: 12587152
[TBL] [Abstract][Full Text] [Related]
14. SSRI-induced parkinsonism may be an early sign of future Parkinson's disease.
Gönül AS; Aksu M
J Clin Psychiatry; 1999 Jun; 60(6):410. PubMed ID: 10401924
[No Abstract] [Full Text] [Related]
15. Serotonin syndrome and fluvoxamine: a case study.
Bastani JB; Troester MM; Bastani AJ
Nebr Med J; 1996 Apr; 81(4):107-9. PubMed ID: 8628448
[TBL] [Abstract][Full Text] [Related]
16. If a patient does not respond to a full dose of fluvoxamine for at least 12 weeks, what alternatives should be considered?
Ravindran AV
J Psychiatry Neurosci; 1998 Mar; 23(2):136. PubMed ID: 9549254
[No Abstract] [Full Text] [Related]
17. Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.
Apter A; Ratzoni G; King RA; Weizman A; Iancu I; Binder M; Riddle MA
J Am Acad Child Adolesc Psychiatry; 1994; 33(3):342-8. PubMed ID: 8169178
[TBL] [Abstract][Full Text] [Related]
18. Case of rapid bilateral cataract development in teenager using selective serotonin reuptake inhibitors.
Kisilevsky E; Margolin EA
Can J Ophthalmol; 2014 Oct; 49(5):e114-5. PubMed ID: 25284112
[No Abstract] [Full Text] [Related]
19. An alert to extrapyramidal side-effects from SSRIs.
Hoaken PC
Can J Psychiatry; 1995 Feb; 40(1):51. PubMed ID: 7874680
[No Abstract] [Full Text] [Related]
20. Violent dreaming and antidepressant drugs: or how paroxetine made me dream that I was fighting Saddam Hussein.
Parish JM
J Clin Sleep Med; 2007 Aug; 3(5):529-31. PubMed ID: 17803018
[No Abstract] [Full Text] [Related]
[Next] [New Search]